Curated Resources — Follow-up care timeline for Benzene-related Acute Myeloid Leukemia

An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.

Featured analysis

Follow-up care timeline for Benzene-related Acute Myeloid Leukemia: Key Facts & Context — detailed background and analysis.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

ClinicalTrials.gov

Reference: ClinicalTrials.gov

Authoritative source for clinical, regulatory, and public-health background reading.

National Institutes of Health (NIH)

Reference: National Institutes of Health (NIH)

Authoritative source for clinical, regulatory, and public-health background reading.